Internal Medicine · San Francisco, CA
NPI
1245406628
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
UCSF Department of Medicine, 505 Parnassus Ave, Room M987
San Francisco, CA, 94143
Phone (415) 476-1528
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
460 services
Medicare patients, 2024
128
Average age 70
Drug cost, 2024
$674K
302 prescriptions
Company payments, 2025
$2,529
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sarah Doernberg was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 110 times for 60 patients. In total Sarah Doernberg billed 460 services in 19 codes, and Medicare paid $32K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-05.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 110 | 60 | $14.38 | $1,582 |
| 99215 Office E&M - Established | Facility | 73 | 43 | $121.59 | $8,876 |
| 99232 Hospital E&M - Subsequent | Facility | 51 | 29 | $69.91 | $3,565 |
| 99233 Hospital E&M - Subsequent | Facility | 50 | 31 | $105.05 | $5,252 |
| 99214 Office E&M - Established | Facility | 34 | 28 | $85.03 | $2,891 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 27 | 14 | $27.80 | $751 |
| 99213 Office E&M - Established | Facility | 23 | 19 | $51.07 | $1,175 |
| 99223 Hospital E&M - Initial | Facility | 21 | 21 | $153.48 | $3,223 |
| G0316 Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 21 | 14 | $27.10 | $569 |
| 99222 Hospital E&M - Initial | Facility | 15 | 14 | $115.53 | $1,733 |
By year: 2022 $28K for 266 services; 2023 $26K for 281 services; 2024 $32K for 460 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sarah Doernberg prescribed most often to Medicare patients was Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim), with 26 prescriptions and refills. In total Sarah Doernberg wrote 302 Medicare prescriptions that cost $674K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 26 | 47 | Under 11 | $287 |
| Minocycline Hcl Generic | 19 | 50 | Under 11 | $923 |
| Methenamine Hippurate Generic | 18 | 30 | Under 11 | $993 |
| Posaconazole Generic | 17 | 17 | Under 11 | $34K |
| Doxycycline Hyclate Generic | 17 | 33 | Under 11 | $588 |
| Ethambutol Hcl Generic | 16 | 30 | Under 11 | $748 |
| Amoxicillin Generic | 15 | 27 | Under 11 | $440 |
| Sirturo Bedaquiline Fumarate | 14 | 14 | Under 11 | $54K |
| Rifampin Generic | 13 | 25 | Under 11 | $765 |
| Arikayce Amikacin Liposomal/Neb.Accessr | 13 | 13 | Under 11 | $188K |
| Sivextro Tedizolid Phosphate | 12 | 12 | Under 11 | $151K |
| Azithromycin Generic | 12 | 28 | Under 11 | $340 |
Brand drugs: 57 claims; generic drugs: 245 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sarah Doernberg $2,529 ($2,529 in general payments such as food, travel and fees) from 1 company. The largest payer was AstraZeneca Pharmaceuticals LP with $2,529.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 2 | $2,529 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.